Nhật Bản chính thức phê duyệt vắcxin Pfizer/BioNTech

Thế giới

Ngày 14/2, Bộ Y tế, Lao động và Phúc lợi Nhật Bản đã thông báo chính thức cấp phép sử dụng vắcxin ngừa bệnh COVID-19 do hãng dược phẩm Pfizer của Mỹ kết hợp BioNTech của Đức sản xuất. Đây là vắcxin ngừa COVID-19 đầu tiên được Nhật Bản cấp phép sử dụng trong nước.

Email Print twitter facebook

22:13 14/02/2021 GMT+7

Đọc nhiều

{publishtime}

{title}
{publishtime}
{title}
{lead}

{title}

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

Theo Kyodo

{name} - {time}

Trả lời

{body}

{name} - {time}

{body}